Literature DB >> 21160963

Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts.

Yasuni Nakanuma1, Motoko Sasaki, Yasunori Sato, Xiangshan Ren, Hiroko Ikeda, Kenichi Harada.   

Abstract

Flat-type "biliary intraepithelial neoplasia (BilIN)" and papillary-type "intraductal papillary neoplasm of the bile duct (IPN-B)" are proposed as precursors of invasive, perihilar intrahepatic cholangiocarcinoma (ICC). Three carcinogenetic pathways are proposed: BilIN progressing to tubular adenocarcinoma, and IPN-B progressing to tubular adenocarcinoma or to colloid carcinoma. Carcinogenesis via BilIN was characterized by mucin core protein 2-/cytokeratin 20-(MUC2-/CK20-) with MUC1 expression, while carcinogenesis via IPN-B leading to tubular adenocarcinoma was associated with MUC1 expression or that to colloid carcinoma with MUC1-negativity. In both the BilIN and IPNB series, the expression of p21, p53, and cyclin D1 was upregulated with histological progression. Interestingly, p53 expression was upregulated at the invasive stage of BilIN, but was low in noninvasive BilIN, while p53 expression was upregulated in IPN-B1 and reached a plateau in IPN-B2 and invasive ICC. Expression of p16(INK4a), which was frequent in BilIN1, was decreased in BilIN-2/3 and invasive carcinoma. EZH2 expression showed a stepwise increase from BilIN to invasive carcinoma. Membranous expression of β-catenin and E-cadherin was more markedly decreased in ICC with BilIN than in ICC with IPNB. Interestingly, disruption of the membranous distribution of β-catenin and E-cadherin seems to result in the invasion and metastasis of carcinoma cells of BilIN and IPN-B expressing MMP-7 and MT1-MMP. Increased expression of cyclin D1 and c-myc was more frequent in the IPNB lineage than BilIN lineage, possibly related to the Wnt signaling pathway associated with the nuclear accumulation of β-catenin. In conclusion, BilIN and IPN-B progress to invasive ICC through characteristic multistep processes.

Entities:  

Keywords:  Biliary intraepithelial neoplasm; Cytokeratin; Intraductal papillary neoplasm; Intrahepatic bile duct; Intrahepatic cholangiocarcinoma; Matrix metalloproteinase; Mucin; Polycomb group protein

Year:  2009        PMID: 21160963      PMCID: PMC2999259          DOI: 10.4254/wjh.v1.i1.35

Source DB:  PubMed          Journal:  World J Hepatol


  49 in total

1.  Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms.

Authors:  Hiroaki Shibahara; Shugo Tamada; Masamichi Goto; Koji Oda; Masato Nagino; Tetsuro Nagasaka; Surinder K Batra; Michael A Hollingsworth; Kohzoh Imai; Yuji Nimura; Suguru Yonezawa
Journal:  Am J Surg Pathol       Date:  2004-03       Impact factor: 6.394

2.  Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.

Authors:  Yoh Zen; Motoko Sasaki; Takahiko Fujii; Tse-Ching Chen; Miin-Fu Chen; Ta-Sen Yeh; Yi-Yin Jan; Shiu-Feng Huang; Yuji Nimura; Yasuni Nakanuma
Journal:  J Hepatol       Date:  2005-12-05       Impact factor: 25.083

3.  Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

Authors:  G Lagna; A Hata; A Hemmati-Brivanlou; J Massagué
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

Review 4.  Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors.

Authors:  Judith Campisi
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

5.  Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction.

Authors:  M Sasaki; Y Nakanuma; Y S Kim
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

6.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

7.  Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.

Authors:  H Matsushime; M E Ewen; D K Strom; J Y Kato; S K Hanks; M F Roussel; C J Sherr
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

8.  Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis.

Authors:  Yoh Zen; Kenichi Harada; Motoko Sasaki; Koichi Tsuneyama; Kazuyoshi Katayanagi; Yui Yamamoto; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

9.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.

Authors:  W S el-Deiry; J W Harper; P M O'Connor; V E Velculescu; C E Canman; J Jackman; J A Pietenpol; M Burrell; D E Hill; Y Wang
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

10.  Interaction of Toll-like receptors with bacterial components induces expression of CDX2 and MUC2 in rat biliary epithelium in vivo and in culture.

Authors:  Hiroko Ikeda; Motoko Sasaki; Akira Ishikawa; Yasunori Sato; Kenichi Harada; Yoh Zen; Hideaki Kazumori; Yasuni Nakanuma
Journal:  Lab Invest       Date:  2007-04-09       Impact factor: 5.662

View more
  27 in total

1.  Biliary intraepithelial neoplasia: a case with benign biliary stricture.

Authors:  Wonkyung Jung; Baek hui Kim
Journal:  Korean J Hepatol       Date:  2011-12

2.  Cystic and micropapillary epithelial changes of peribiliary glands might represent a precursor lesion of biliary epithelial neoplasms.

Authors:  Yasunori Sato; Kenichi Harada; Motoko Sasaki; Yasuni Nakanuma
Journal:  Virchows Arch       Date:  2014-01-24       Impact factor: 4.064

3.  Intraductal papillary neoplasm of the bile duct, gastric type, arising in the intrapancreatic common bile duct could progress to colloid carcinoma: report of a case.

Authors:  Shogo Tajima; Akihiko Ohata; Kenji Koda; Yasuhiko Maruyama
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 4.  Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis.

Authors:  Gábor Lendvai; Tímea Szekerczés; Idikó Illyés; Réka Dóra; Endre Kontsek; Alíz Gógl; András Kiss; Klára Werling; Ilona Kovalszky; Zsuzsa Schaff; Katalin Borka
Journal:  Pathol Oncol Res       Date:  2018-11-17       Impact factor: 3.201

Review 5.  Preneoplastic conditions underlying bile duct cancer.

Authors:  Lena Sibulesky; Justin Nguyen; Tushar Patel
Journal:  Langenbecks Arch Surg       Date:  2012-03-06       Impact factor: 3.445

6.  Pathological classification of intrahepatic cholangiocarcinoma based on a new concept.

Authors:  Yasuni Nakanuma; Yasunori Sato; Kenichi Harada; Motoko Sasaki; Jing Xu; Hiroko Ikeda
Journal:  World J Hepatol       Date:  2010-12-27

Review 7.  Early detection of intrahepatic cholangiocarcinoma.

Authors:  Mami Hamaoka; Kazuto Kozaka; Osamu Matsui; Takahiro Komori; Takashi Matsubara; Norihide Yoneda; Kotaro Yoshida; Dai Inoue; Azusa Kitao; Wataru Koda; Toshifumi Gabata; Satoshi Kobayashi
Journal:  Jpn J Radiol       Date:  2019-08-01       Impact factor: 2.374

Review 8.  Pathological diagnosis of flat epithelial lesions of the biliary tract with emphasis on biliary intraepithelial neoplasia.

Authors:  Yasunori Sato; Motoko Sasaki; Kenichi Harada; Shinichi Aishima; Toshio Fukusato; Hidenori Ojima; Yae Kanai; Masayoshi Kage; Yasuni Nakanuma; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2013-04-25       Impact factor: 7.527

9.  Histological characteristics of biliary intraepithelial neoplasia-3 and intraepithelial spread of cholangiocarcinoma.

Authors:  Yasunori Sato; Kenichi Harada; Motoko Sasaki; Yasuni Nakanuma
Journal:  Virchows Arch       Date:  2013-02-28       Impact factor: 4.064

10.  Successful treatment of biliary intraepithelial neoplasia in the common bile duct via local excision: A case report.

Authors:  Wei Wang; Wei Chen; Kewei Li; Jian Wang
Journal:  Oncol Lett       Date:  2016-03-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.